These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 16183523)
21. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. Johanson V; Tisell LE; Olbe L; Wängberg B; Nilsson O; Ahlman H Br J Cancer; 1999 Jun; 80(8):1259-61. PubMed ID: 10376980 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345 [TBL] [Abstract][Full Text] [Related]
23. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas. Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641 [TBL] [Abstract][Full Text] [Related]
24. [Metachronous cancer of the gastro-intestinal tract with signs of endocrine-cell differentiation]. Turbin DA; Perevoshchikov AG; Chistiakova OV; Konstantinova LN; Kirichenko OP; Fleĭshman EV Arkh Patol; 1996; 58(4):28-32. PubMed ID: 8967859 [TBL] [Abstract][Full Text] [Related]
25. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours. O'Toole D; Ruszniewski P Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529 [TBL] [Abstract][Full Text] [Related]
26. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283 [TBL] [Abstract][Full Text] [Related]
28. [Malignancy: treatment and prognosis of gastrointestinal and pancreatic endocrine neoplasia: retrospective study of a series of 16 cases]. Pansini GC; Lanzara S; Feo CV; Zamboni P; Liboni A; Ambrosio MR; Marzola A; Feggi L Ann Ital Chir; 2001; 72(4):413-21; discussion 422. PubMed ID: 11865693 [TBL] [Abstract][Full Text] [Related]
29. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract. Solcia E; Rindi G; Paolotti D; La Rosa S; Capella C; Fiocca R Ann Oncol; 1999; 10 Suppl 2():S9-15. PubMed ID: 10399027 [TBL] [Abstract][Full Text] [Related]
31. Tumour biology and histopathology of neuroendocrine tumours. Klöppel G Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570 [TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features. Chang S; Choi D; Lee SJ; Lee WJ; Park MH; Kim SW; Lee DK; Jang KT Radiographics; 2007; 27(6):1667-79. PubMed ID: 18025510 [TBL] [Abstract][Full Text] [Related]
35. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond. Sorbye H; Baudin E; Perren A Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724 [TBL] [Abstract][Full Text] [Related]
37. [Definition and histologic characterization of neuroendocrine tumors]. Saint-André JP; Valo I; Guyétant S Rev Prat; 2002 Feb; 52(3):250-5. PubMed ID: 11925713 [TBL] [Abstract][Full Text] [Related]
38. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future]. Scoazec JY; Couvelard A; Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836 [TBL] [Abstract][Full Text] [Related]
39. The tumours of the endocrine pancreas. Rindi G; Paolotti D; LaRosa S; Solcia E Eur J Histochem; 1998; 42 Spec No():63-6. PubMed ID: 10076771 [TBL] [Abstract][Full Text] [Related]
40. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours]. Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]